+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 20Years +
All Genders
ID05304481

Evaluating Activated T Lymphocytes ATL Treatment Safety and Effectiveness in Hepatocellular Carcinoma Patients After Curative Therapy

Led by Lukas Biomedical Inc. · Updated on 2026-09-01

95

Participants Needed

14

Research Sites

43 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the efficacy and safety of autologous Activated T Lymphocytes ATL as a preventive immunotherapy in patients with hepatocellular carcinoma HCC who have undergone curative treatment. This Phase II, open-label, single-arm, multicenter study focuses on patients with Stage I, II, or IIIa HCC, reflecting a previous studys patient distribution. The goal is to assess relapse-free survival over 12 months following ATL administration. Eligible patients will receive ten intravenous infusions of ATL at specific weeks 1, 2, 3, 4, 6, 8, 10, 14, 18, and 22. Before treatment, peripheral blood is collected at least 28 days prior to manufacturing the ATL agent. The first three patients receive the ATL doses in a staggered manner to monitor safety. A Data and Safety Monitoring Board will review safety data after 10% of participants complete four ATL infusions to decide on study continuation or adjustments. Participants will be closely monitored through various assessments including blood tests, imaging MRI or CT scans, and evaluations of performance status and quality of life using standardized questionnaires. Safety measures include monitoring adverse events, vital signs, lab values, ECG results, and physical exams over a period of up to 76 weeks. The primary outcome is relapse-free survival at 12 months post-treatment initiation, with additional secondary outcomes assessing overall survival, biomarkers, and functional status changes.

CONDITIONS

Brief Title

Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma

Research Team

E

Eric Tang, M.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here